## Abstract Many cases of acute hepatitis remain undiagnosed and the hepatitis E virus (HEV) is emerging in industrialized countries. The aim of this study was to assess the role HEV as causative agent in acute non‐A, non‐B, and non‐C hepatitis patients in Hungary. 10.5% of the 264 acute non‐A, non
Case report: Role of hepatitis E virus in the etiology of community-acquired non-A, non-B hepatitis in greece
✍ Scribed by Nicolaos C. Tassopoulos; Krzysztof Krawczynski; Angelos Hatzakis; Antigoni Katsoulidou; Ioanna Delladetsima; Maria G. Koutelou; Dimitrios Trichopoulos
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 515 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The aim of this study was to determine the frequency of hepatitis E virus (HEV) infection in a population of Greek adults with community‐acquired (sporadic) non‐A, non‐B hepatitis found to be seronegative for antibodies to hepatitis C virus (anti‐HCV). All patients admitted to the Liver Unit of Western Attica General Hospital and diagnosed as having acute community‐acquired non‐A, non‐B hepatitis between February, 1986, and May, 1990, were enrolled in follow up studies (n = 66). Nineteen patients with HCV infection and 11 patients with acute non‐A, non‐B, non‐C hepatitis that progressed to chronicity were excluded. Convalescent sera were tested for antibody to HEV (anti‐HEV) by a fluorescent antibody blocking assay in 33 of 36 eligible patients. One of the 33 (3%) patients was found to be positive for anti‐HEV. Anti‐HEV testing of all 20 available serum specimens from this patient showed evidence of anti‐HEV seroconversion at the fourth week after the onset of hepatitis. The patient had not travelled abroad or within Greece or had not had apparent contact with people from foreign countries for the previous 3 months. These data show that HEV infection is not a major cause of community‐acquired non‐A, non‐B hepatitis in Greece. However, the reported case of HEV hepatitis suggests that HEV may retain a low endemicity in Greece. More extensive seroprevalence studies are needed for an accurate estimation of the extent of HEV infection in the southeastern European countries. © 1994 Wiiey‐Liss, Inc.
📜 SIMILAR VOLUMES
The etiology of sporadic acute hepatitis was studied in 334 consecutive patients from Taiwan (237 men and 97 women, aged 16-81 years), with emphasis on the role of hepatitis C virus (HCV), hepatitis E virus (HEV), and GB virus-C/hepatitis G virus (GBV-C/HGV) in acute non-A, non-B (NANB) hepatitis an
## Abstract Sera from 30 patients with community‐acquired, biopsy‐proven chronic non‐A, non‐B hepatitis (NANBH) were tested for antibodies to the C100 protein of hepatitis C virus (HCV). The 20 patients who showed reactivity in this assay were followed prospectively for 6 months, during which time
We developed a polymerase chain reaction assay for the direct detection of hepatitis B virus in paraffin-embedded liver tissue and applied this assay to determine whether hepatitis B virus DNA exists in livers with chronic hepatitis non-A, non-B. Fifty five liver biopsy samples were studied: 11 from
been linked with FHF in neonates, pregnancy, immunocom-Members of the herpes virus family and hepatitis B promised patients, and apparently healthy individuals. [5][6][7][8] Epvirus (HBV) have been implicated as etiologic agents in stein-Barr virus (EBV) infection may cause acute liver failure non-A